The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

Aphios Corporation is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its patent application (Application No. 17/699,359), titled ...

(The Center Square) – The U.S. Department of Health and Human Services has removed mRNA COVID-19 vaccines from children and ...

Kennedy Jr. -- are restricting access to COVID shots that were a signature accomplishment of President Trump's first term and ...

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: ...

Larry Saltzman has blood cancer. He's also a retired doctor, so he knows getting COVID-19 could be dangerous for him—his ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

The expression of symptoms of viral infections is a byproduct of complex virus-host molecular pathways. These remain largely ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...